- Learn and Network
- Info Hub
- Partners & Supporters
- News & Views
- Regional Network
- Get involved
- My IIRSM
IIRSM Wins European Tender by European Patent Office
Date of Issue: Monday, 7 March, 2016
The European Patent Office (EPO), the No 1 globally ranked Patent Office for the last 5 years and the second largest European Institute based in Munich, The Hague, Berlin, Vienna and Brussels, has appointed the International Institute of Risk and Safety Management (IIRSM), in partnership with WellKom International and Ergosquad, to deliver its first pan-European Occupational Health and Safety Risk Assessment (OHSRA) based on global standards and best practice.
Following an open tender process, The European Patent Office appointed IIRSM to deliver a comprehensive programme of risk assessments. These will address not only the traditional health and safety risks but also issues relating to the wellbeing of employees and their exposure to ergonomic risks.
The project aims to encourage all levels of the organisation from senior management, through line managers to the individual employees to take ownership of managing these risks.
The assessment of the wellbeing and ergonomic risks will make use of on-line software to analyse individual exposures and recommend ways of reducing the exposure which will not only benefit the individuals but also the business as a whole.
IIRSM’s multi-disciplinary team will carry out a comprehensive OHSRA covering safety, psycho-social and physical well-being. The project team capability ensures that it can deliver a traditional risk assessment against international and European standards as well as utilising innovative tools for personal profiling of individual wellbeing and 3d visuals of bodily posture to address workplace ergonomics.
“I am extremely proud that the Institute has been selected to help to deliver such an important project” said Phillip Pearson, Chief Executive of IIRSM. “I am confident that the IIRSM members and partners on the project team will deliver a first class service to EPO”.